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Veer P. Bhavanandana and Onn Haji Hashim*ac
Mucins and mucin-type glycoproteins, collectively referred to as mucin-type O-glycans, are implicated in
many important biological functions and pathological conditions, including malignancy. Presently, there
is no reliable method to measure the total mucin-type O-glycans of a sample, which may contain one or
more of these macromolecules of unknown structures. We report the development of an improved
microassay that is based on the binding of lectins to the unique and constant GalNAc-Ser/Thr structural
feature of mucin-type O-glycans. Since the sugar–amino acid linkage in the mucin-type O-glycans is
invariably cryptic, we ﬁrst chemically removed the heterogeneous peripheral and core saccharides of
model glycoconjugates before examining for their interactions using an enzyme-linked lectin assay
(ELLA). Desialylation of the model glycoconjugates led to maximal binding of the lectins but additional
treatments such as Smith degradation did not result in increased binding. Of the lectins tested for their
ability to probe the desialylated O-glycans, jacalin showed the highest sensitivity followed by
champedak galactose binding (CGB) lectin and Vicia villosa agglutinin. Further improvement in the
sensitivity of ELLA was achieved by using microtiter plates that were pre-coated with the CGB lectin,
which increased the speciﬁcity of the assay to mucin-type O-glycans. Finally, the applicability of the
developed sandwich ELLA to crude samples was demonstrated by estimating trace quantities of the
mucin-type O-glycans in the human serum.Introduction
Mucins are large glycoproteins containing many clusters of
glycosylated serines and threonines in tandem repeat regions.1–3
Mucins andmucin-type glycoproteins, referred to as mucin-type
O-glycans†, are implicated in many important biological func-
tions and pathological conditions including malignancy.1,4,5 In
cancer, the over-expression and aberrant glycosylation of cell
surface glycoconjugates are among the phenotypic changes thatof Medicine, University of Malaya, 50603
@um.edu.my; Fax: +603 7967 4957
ation, Penn State University College of
s Research, University of Malaya, 50603
confusing and keeps changing as new
are discovered. The term, O-glycan or
ally used to refer to glycoconjugates in
e protein via an O-glycosidic linkage.
hose having saccharides linked via the
xyl group of serine and threonine.
having saccharides, including GlcNAc-,
y to proteins. Therefore, the term
to distinguish glycoconjugates having
ans. In this article the term O-glycans
glycans.
9are widely recognized.6 The tumor cells of cancer patients
actively secrete and/or shed, during cell turnover, a repertoire of
O-glycans into the circulation.7,8 Hence, specic detection and
quantitation of circulating tumor-associated O-glycans will be
extremely benecial for the early diagnosis and treatment of
cancer. In fact, immunological methods are available for
detection of cancer-associated O-glycans such as MUC1, CA125
and CA19-9.9–11 However, these assays based on monoclonal
antibody recognition of one specic epitope are of very narrow
specicities and therefore not suitable for detection of the total
O-glycan content of samples such as serum, saliva, urine or
tissue extracts.
A problem in developing a single assay for O-glycans is the
heterogeneity of their saccharides.12 However, in contrast to the
high variability of the peripheral saccharides, which are based
on eight diﬀerent core structures, the sugar–amino acid linkage
in O-glycans is a unique and constant feature. Previously, one of
us (VPB) had developed an assay for the estimation of O-glycans
that was based on the specic chemistry of the GalNAc-Ser/Thr
linkage.13 Since the sensitivity of this colorimetric assay is very
limited, in this study we explored the use of lectins to estimate
trace amounts of O-glycans.
The aim of the present study was to develop a sensitive assay
for the determination of the O-glycan content of a sample. ThisThis journal is ª The Royal Society of Chemistry 2013
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View Article Onlinetask was complicated by the fact that the saccharides in this
class of glycoconjugates are highly heterogeneous.14,15 Firstly,
the saccharides in O-glycans are formed by chain elongation,
branching and chain terminations of eight diﬀerent core
structures resulting in a bewildering array of structures.12
Secondly, the total O-glycan content of a biological sample is
likely to be constituted by a mixture of molecules of unknown
saccharide structures. However, all O-glycans have a unique
structural feature that distinguishes them from other classes of
glycoconjugates (N-glycans, glycolipids and proteoglycans/
glycosaminoglycans), i.e., the presence of a GalNAc residue at
the reducing termini of the saccharides, which is to be linked to
specic serine or threonine residues in the core protein. In fact,
the sensitivity of these GalNAc-Ser/Thr linkages to mild alkaline
conditions has been very valuable in the characterization16,17
and for colorimetric estimation of O-glycans.13
Our strategy was rstly to maximize the exposure of the
cryptic sugar–amino acid linkage by removal of the heteroge-
neous peripheral and core saccharides. Secondly, we deter-
mined the best lectin to quantitate the exposed linkage region
of O-glycans by Enzyme-Linked Lectin Assay (ELLA). Towards
this objective, model glycoconjugates (PGM, BSM, PSM, and
fetuin) were chemically treated to remove peripheral saccha-
rides. The untreated and treated glycoconjugates were then
tested for their interaction with jacalin and VVA as they are
known to best bind to Galb1,3GalNAca-Ser/Thr (T-antigen) and
GalNAcaSer/Thr (Tn-antigen), respectively.18,19 CGB lectin,
previously isolated in this laboratory and found to interact with
the T-antigen,20 was also tested with the model glycoconjugates.
The modications and lectin combination that gave the highest
sensitivity were then used to develop an assay. Finally, the assay
was evaluated for its ability to quantitate trace quantities of
O-glycans in serum samples.Experimental
Materials
Porcine gastric mucin (PGM) was partially puried from
commercial preparations (Sigma-Aldrich, St. Louis, MO, USA) as
described.21 Bovine submaxillary mucin (BSM) and porcine
submaxillary mucin (PSM) were prepared from fresh glands as
previously described.22 Alpha1-acid glycoprotein (AGP) and
ovomucoid (trypsin inhibitor) were obtained from Sigma-
Aldrich, St. Louis, MO, USA. Serum samples were obtained from
healthy donors with the consent of the individuals. Jacalin, VVA,
biotinylated jacalin and biotinylated VVA were purchased from
E-Y Labs (San Mateo, CA, USA). CGB lectin was extracted and
puried from the seeds of champedak in the laboratory as
previously described.20,23 Streptavidin-alkaline phosphatase and
p-nitrophenyl phosphate were obtained from Sigma-Aldrich.
ELISA immunoassay plates with medium binding capacity were
purchased from Jet-Bioll (Guangzhou, China). EZ-Link sulfo-
NHS-biotin and Pierce bicinchoninic acid (BCA) protein assay
kit were purchased from Thermosher Scientic (Rockford, IL,
USA). All other chemicals were purchased from Sigma-Aldrich
(St. Louis, MO, USA).This journal is ª The Royal Society of Chemistry 2013Modication of O-glycans
Chemical desialylation was performed by treatment with mild
acid hydrolysis (0.1 N sulfuric acid, 80 C, 60 minutes) and the
asialo product was recovered by neutralization with sodium
hydroxide followed by dialysis against distilled water and
lyophilization. The lyophilized asialo sample was reconstituted
in ultra pure water. The protein concentration was determined
by the BCA microassay.
Native as well as desialylated mucins were subjected to
Smith degradation,24,25 which involved mild periodate oxidation
of the sample with 0.05 M sodium periodate in 0.05 M sodium
acetate, pH 4.5 buﬀer at 4 C for 18 hours. The aldehyde groups
generated on the susceptible saccharides were reduced by
treatment with 0.15 M sodium borohydride in 0.1 M sodium
borate buﬀer. Aer incubation for three hours at room
temperature, the reaction was terminated by neutralization with
acetic acid. The samples were nally subjected to mild acid
hydrolysis (0.025 M sulfuric acid at 80 C for 60 minutes) and
neutralized with 1.0 N sodium hydroxide. Aer each treatment
the sample was recovered by dialysis versus distilled water at
4 C and lyophilized. The Smith-degraded samples were
reconstituted and the protein concentration determined by the
BCA microassay.Analysis of monosaccharides of native and modied
glycoproteins
For neutral sugars and hexosamines, the samples were hydro-
lyzed with 2 N triuoroacetic acid at 100 C for six hours. The
hydrolysates were dried in a vacuum centrifuge (Speed-Vac)
(Labconco Corporation, Kansas City, Missouri), reconstituted in
HPLC grade water and analyzed on a Carbopac PA10 high pH
anion-exchange column (HPAEC) using a Dionex BioLC HPLC
by isocratic elution with 16 mM sodium hydroxide and pulsed
amperometric detection.26 Sialic acids were determined aer
hydrolysis with 0.1 N sulfuric acid at 80 C for one hour. The
hydrolysates were neutralized with barium carbonate, centri-
fuged and the supernatant was dried, reconstituted as
described above and analyzed by HPAEC as described by Manzi
et al.27 The response factors for the monosaccharides were
determined using standard sugars.Biotinylation of lectins
Biotinylated CGB lectin was prepared by adding suﬃcient
volume of 10 mg ml1 EZ-Link sulfo-NHS-biotin reagent to a
solution of CGB lectin (5 mg ml1 in PBS). The solution was
mixed gently at room temperature for 60 minutes. The reaction
mixture was dialyzed for two days with two changes of distilled
water. The amount of biotinylated CGB lectin recovered in the
retentate was determined by using BCA protein microassay.Microtiter plate lectin binding assay
ELLA was performed either on samples directly coated on 96
well microtiter plates or on samples bound to lectin pre-coated
plates. For coating of plates, 50 ml of the sample or lectin diluted
in coating buﬀer (0.05 M sodium carbonate, pH 9.6) was addedAnalyst, 2013, 138, 3522–3529 | 3523
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View Article Onlineto each well and incubated overnight at 4 C. The wells were
washed thrice with TBS-T (0.01 M Tris–HCl, pH 8.0, 0.05%
Tween-20 and 0.05% sodium azide) and blocked by incubating
with the wash buﬀer for 30minutes. In the case of the lectin pre-
coated plate, 50 ml test sample in phosphate buﬀered saline
(PBS) was added to each well, incubated for 90 minutes at 20 C
and the unbound material was removed by washing as
described above.
In both cases, the quantity of O-glycans in the test sample
bound to the plate was determined as follows: 50 ml of diluted
biotinylated lectin in TBS-T was added to each well and incu-
bated for 90 minutes. The solution was removed and the wells
washed three times. Fiy ml of avidin alkaline phosphatase
(1 : 10 000) in TBS-T was then added to the wells and incubated
for 90 minutes. The plate was washed thrice before adding 50 ml
of 1 mg ml1 p-nitrophenyl phosphate in substrate buﬀer (0.05
M sodium carbonate, pH 9.6, 1 mM MgCl2). Aer appropriate
incubation time, typically 20–30 min at 20 C, the absorbance
was read at 415 nm on a microplate reader (Bio-Rad, USA).
Checkerboard assays were performed with serial dilutions of
each ligand and lectin to determine optimal concentrations.28,29
All ELLAs were done in triplicate and the mean values plotted.
Typically, the variation (standard deviation) between the repli-
cates was between 5 and 10% of the mean values.
Results
Eﬀects of chemical treatment on the glycoproteins
The eﬀects of acid hydrolysis and Smith degradation on the
oligosaccharide structures were tested using PGM, BSM and
PSM as well as fetuin. The concentrations of the mono-
saccharides remaining in the treated samples were determined
as described in the Experimental section. The results of the
analysis, expressed as molar ratios relative to GalNAc, of PGM
before and aer treatment are summarized in Table 1. Mild acid
hydrolysis, as expected, removed all of the sialic acids from
PGM and all the test glycoconjugates. This treatment also
removed varying amounts of fucose for example, about 38%
from PGM (Table 1) and 40% from PSM (not illustrated). Mild
acid hydrolysis did not signicantly aﬀect the GlcNAc, galactose
and GalNAc contents of PGM (Table 1). Subjecting the desialy-
lated samples to Smith degradation resulted in removal of
varying amounts of the now exposed penultimate saccharides.Table 1 Carbohydrate composition of pig gastric mucin (PGM) after diﬀerent
chemical treatments to modify the saccharide chains
Molar ratio of monosaccharides
(with GalNAc as 1.00)
GalNAc GlcNAc Gal Fuc Sialic acid
PGM 1.00 2.03 1.25 0.65 0.15
asialoPGM 1.00 1.87 1.23 0.40 0.00
Smith-degraded PGMa 1.00 1.86 0.64 0.00 0.10
Smith-degraded asialoPGMa 1.00 1.71 0.52 0.00 0.00
a Sample subjected to Smith degradation as described in the
“Experimental” section.
3524 | Analyst, 2013, 138, 3522–3529Thus, Smith-degradation of asialoPGM resulted in the loss of
100% of fucose, 58% of galactose and 9% of GlcNAc (Table 1).
When PGM was directly subjected to Smith degradation, about
8% of GlcNAc, 49% of galactose, 100% of fucose and 33% of
sialic acid were lost. This indicates that in PGM, while all of the
terminal fucose is susceptible to periodate cleavage, about two-
thirds of sialic acid is protected as a result of O-acetylation.30
Lectin binding of native and chemically treated mucins
ELLA was performed to evaluate the ability of PGM, BSM, PSM
and fetuin to interact with biotinylated jacalin, VVA and CGB
lectin before and aer the saccharide modications as
described above. In all cases, 50 ml of a solution of the test
glycoconjugates at 1 mg protein per ml of coating buﬀer was
used to coat the wells. Fig. 1 illustrates results of the experi-
ments, which involved 12 diﬀerent combinations of lectins and
chemical treatments. Of the three lectins tested, jacalin
demonstrated the highest detection sensitivity for all the native
glycans tested. Binding of all three lectins was enhanced aer
desialylation by mild acid hydrolysis. For example, the
substantially increased binding of VVA to asialoBSM compared
to BSM and CGB to asialoPSM compared to PSM can be noted in
Fig. 1b3 and 1c2, respectively. The inuence of Smith-degra-
dation on the ability of the desialylated glycans to interact with
the three lectins was highly variable. While Smith degradation
substantially reduced the binding of VVA to asialoBSM
(Fig. 1b3) and asialoPSM (Fig. 1c3), it had no notable eﬀect on
the binding of jacalin to asialoPGM (Fig. 1a1). In contrast, the
binding of CGB to asialoPGM was signicantly increased aer
Smith degradation (Fig. 1a2). We also examined the interaction
of the lectins to glycans that were directly subjected to Smith-
degradation to determine whether prior desialylation was
essential. Again the results were variable; for example, binding
of jacalin to PGM and VVA to BSM was improved aer Smith
degradation (Fig. 1a1 and b3) but binding of jacalin to BSM
(Fig. b1) and to fetuin (Fig. 1d1) was drastically reduced. An
important observation was that virtually in all cases, the
binding of the lectins to the Smith-degraded glycans was less
than that to the corresponding asialo glycans. Based on these
and other experiments further studies were carried out
primarily using asialoPGM and asialoBSM as ligands and
biotinylated jacalin as the probe lectin.
Direct versus sandwich ELLA
Because of the high level of glycosylation, O-glycans, in general,
are known tobind toplasticmicrotiter plates ratherpoorly. Thus,
we performed a series of experiments to compare the binding of
biotinylated jacalin to O-glycans that were directly coated onto
microtiter plates versus those that interacted with lectins that
were pre-coated onto the plates (i.e. direct ELLA versus sandwich
ELLA). The optimal concentration of lectin for coating the plates
was rst determined. In a typical experiment, the wells of the
microtiter plates were coated by incubating with 50 ml of solu-
tions containing 0.25, 0.50, 1.00 and 2.00 mg of jacalin in the
coating buﬀer. Aer washing to remove unbound lectin, the
wells were incubated for 90 minutes with 50 ml of a solution ofThis journal is ª The Royal Society of Chemistry 2013
Fig. 1 Binding of serially diluted biotinylated lectins to various glycoconjugates. Panels A, B, C and D refer to PGM, BSM, PSM and fetuin, before (C) and after chemical
treatment to modify the saccharide chains. The glycoconjugates were subjected to desialylation by mild acid hydrolysis (-), Smith degradation (B) and both
desialylation and Smith degradation (,).
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View Article OnlineasialoPGM (1 mg protein per ml PBS). They were washed, incu-
bated with a serial dilution of biotinylated jacalin at a starting
concentration of 5 mg ml1 and further processed as described
above. The results revealed that the absorbance increased byThis journal is ª The Royal Society of Chemistry 201347.0, 92.1 and 110.5% when the coating concentration of jacalin
was increased from 0.25 to 0.50, 1.00 and 2.00 mg per well,
respectively. Based on this, 1 mg lectin per well was chosen as the
coating concentration in all subsequent experiments.Analyst, 2013, 138, 3522–3529 | 3525
Fig. 2 Development of ELLA using microtitre plates precoated with diﬀerent
lectins. BSM (panel a), PGM (panel b) and serum (panel c) were subjected to mild
acid treatment to desialylate the glycoconjugates. Binding of serially diluted
biotinylated jacalin to desialylated BSM, PGM and serum was tested using
microtitre plates that were either not precoated (,) or precoated with jacalin
(C), CGB lectin (-) and VVA (B).
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View Article OnlineWe next performed a series of experiments to compare the
binding of biotinylated jacalin to asialoBSM and asialoPGM
that were directly coated onto microtiter plate wells versus those
that interacted with 1.0 mg of jacalin, CGB lectin or VVA that was
pre-coated to the wells. Our results showed that pre-coating of
wells with a lectin substantially increased the sensitivity of the
ELLA for the ligands tested (Fig. 2). Thus, the binding of bio-
tinylated jacalin to asialoBSM and asialoPGM was substantially
increased when they were bound to the lectin pre-coated wells
compared to the uncoated wells (Fig. 2a and b). CGB lectin
coated wells gave the highest reading followed by jacalin in both
cases of asialoBSM and asialoPGM. When VVA was used as the
coating lectin, increased sensitivity was obtained with asia-
loBSM but not with asialoPGM.
Eﬀect of N-glycans on sandwich ELLA for O-glycans
The interference of N-glycans in our sandwich ELLA was tested
using asialoAGP and ovomucoid, a lactosaminyl and an oligo-
mannosyl N-glycan respectively. These N-glycans did not show
signicant interaction in the CGB lectin–jacalin (Fig. 3a) and
jacalin–jacalin sandwich ELLA (Fig. 3b) even at a concentration
of 1000 ng protein per ml. We also evaluated the presence of 500
ng protein per ml of asialoAGP during CGB–jacalin sandwich
ELLA of 5 ng protein per ml of asialoBSM. The results presented
in Fig. 3c clearly show that the presence of a 100-fold excess of
an N-glycan had hardly any eﬀect in the CGB lectin–jacalin
sandwich ELLA of an O-glycan.
Detection of O-glycoproteins in serum
To evaluate the applicability of the developed sandwich ELLA
for the estimation of O-glycans in crude samples, we carried out
a few preliminary experiments using human serum. Since
desialylation increased binding of the lectins to all the test
glycoconjugates, the serum samples were also rst subjected to
mild acid hydrolysis. The desialylated serum samples were then
subjected to direct ELLA and sandwich ELLA using biotinylated
jacalin as the probe lectin and CGB lectin, jacalin and VVA as
the coating lectins. Typical results of the binding of biotinylated
jacalin to the desialylated O-glycans in serum are illustrated in
Fig. 2c. It can be seen that the absorbance readings are highest
when wells were precoated with CGB lectin. Relatively high
absorbance readings were also obtained with wells coated with
jacalin but the readings were very low when wells were uncoated
or coated with VVA.
Next, three human serum samples (N1, N2 and N3) were
desialylated and subjected to sandwich ELLA using biotinylated
jacalin as the probe lectin, and jacalin and CGB lectin as the
coating lectins. In each assay, asialoBSM in the range of 0.08 to
5.0 mg protein per ml was included as the standard. Typical
results obtained for one serum sample (N2) and the asialoBSM
standard by jacalin–jacalin sandwich ELLA and CGB lectin–
jacalin sandwich ELLA are illustrated in Fig. 4. Using the results
of the jacalin–jacalin sandwich ELLA (Fig. 4a and b) the
O-glycan contents of N1, N2 and N3 were calculated to be 36.0,
36.1 and 36.8 pg asialoBSM protein per mg serum protein,
respectively. The corresponding values calculated from the3526 | Analyst, 2013, 138, 3522–3529 This journal is ª The Royal Society of Chemistry 2013
Fig. 3 Inﬂuence of N-Glycans on the sandwich ELLA for O-glycans. AsialoAGP
and ovomucoid show minimum binding in CGB lectin–jacalin (panel a) and
jacalin–jacalin (panel b) sandwich ELLA for asialoPGM and asialoBSM. Panel c
illustrates the results of CGB lectin–jacalin sandwich ELLA on serially diluted
solution of asialoBSM (5 ngml1) and amixture of asialoBSM (5 ng protein per ml)
and asialoAGP (500 ng protein per ml).
This journal is ª The Royal Society of Chemistry 2013
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View Article Onlineresults of the CGB lectin–jacalin sandwich ELLA were 27.7, 30.3
and 31.1 pg asialoBSM protein per mg serum protein,
respectively.Discussion
In the present study, we have targeted the binding of lectins to
the unique GalNAc-Ser/Thr linkage feature for the development
of an assay to quantify O-glycans in crude biological samples.
Since the GalNAc-Ser/Thr linkages are invariably cryptic in
O-glycans, it was necessary to rst remove at least some of the
peripheral saccharides. One approach to do this is by treatment
with enzymes. However, this will require a supply of several
highly puried glycosidases. Another approach is using chem-
ical treatment such as mild acid hydrolysis and periodate
oxidation.24 The rationale for periodate oxidation was that it
would cleave peripheral saccharides but not the linkage GalNAc.
The GalNAc-Ser/Thr will be preserved in the majority of the
O-glycan saccharides since they are based on core structures 1 to
5 in which position 3 of GalNAc is substituted making it resis-
tant to periodate oxidation.24,25,29 However, our experiments
with model glycoconjugates revealed that desialylation by mild
acid hydrolysis alone was suﬃcient for maximal binding and
periodate oxidation did not further increase binding of the
lectins selected for this study. These experiments also showed
that of the three lectins tested, jacalin provided the highest
sensitivity of binding to the desialylated O-glycans. This is
probably due to the reported broad specicity of jacalin for
O-glycans.14,31,32 Therefore, biotinylated jacalin was selected as
the most suitable detecting reagent in all subsequent
experiments.
As expected, our experiments showed that the sandwich
binding approach in which a lectin was used to capture the
O-glycans is superior to direct coating of the sample onto the
plastic microtiter plates. This is particularly relevant for crude
samples having high levels of non-glycosylated proteins, such as
serum, which are more likely to bind to plastic than the heavily
glycosylated O-glycan molecules that are of much lower
concentrations. When diﬀerent lectins were tested as the
coating capture reagent, the best sensitivity in the developed
sandwich ELLA was obtained using CGB lectin. This is in
agreement with our earlier data suggesting that the CGB lectin
and jacalin, despite having close structural similarities,33,34
demonstrated slightly distinct binding specicities.20
When the developed CGB lectin–jacalin and jacalin–jacalin
sandwich ELLAs were used to estimate the O-glycan content of
three human serum samples, the values obtained using the two
assays were slightly diﬀerent. Clearly, the developed assays are
not likely to yield absolute values for the O-glycan content of test
samples such as body uids containing one or more O-glycans
of unknown structures. Aside from the type of O-glycan used as
the standard, the values obtained are also dependent on the
lectins used in the sandwich ELLA. In the present study,
the higher values obtained using the jacalin–jacalin sandwich
ELLA compared to CGB lectin–jacalin sandwich ELLA may
be due to the non-specic interaction of jacalin since the lectin
has previously been reported to show weak interaction withAnalyst, 2013, 138, 3522–3529 | 3527
Fig. 4 Estimation of O-glycans in human serum samples subjected to mild acid treatment. Sandwich ELLA was performed using asialoBSM as the standard O-glycan
(panels a and c). TheO-glycans of asialo-serum samples were estimated using jacalin (panels a and b) or CGB lectin (panels c and d) as the coating lectin and biotinylated
jacalin as the probe lectin.
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View Article Onlinenon-O-glycosylated glycoproteins.31,35 But more importantly, the
results illustrated in Fig. 2 clearly demonstrate that the sand-
wich assay using CGB as the coating lectin gave the highest
sensitivity not only with model O-glycans (BSM and PGM) but
also with serum, a crude biological sample. Further, in a
sandwich assay it is preferable to use two diﬀerent lectins rather
than the same lectin jacalin, for both coating and probing
purposes. Hence, we conclude that for the analysis of crude
samples such as serum the sandwich assay using CGB lectin as
the capture lectin and jacalin as the probe lectin is more suited
than the one using jacalin as both the capture and probe lectin.Conclusions
In the present study, a method to detect asialo mucin type
O-glycans was developed using champedak galactose binding
lectin and biotinylated jacalin. This method was more sensitive
when tested on serum samples and may be easily applied in the
analysis of a large number of biological uid samples. The CGB
lectin–jacalin sandwich ELLA that is reported here will be most3528 | Analyst, 2013, 138, 3522–3529valuable in studies comparing the levels of O-glycans in bio-
logical uid samples of healthy individuals with patients with a
variety of diseases.Acknowledgements
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